Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.
about
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant womenNew Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for InfluenzaVaccination of healthcare workers: A reviewSafety of influenza vaccination in children with allergic diseasesVaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptakeInternational Consensus (ICON): allergic reactions to vaccinesReplication-competent fluorescent-expressing influenza B virusThe Saudi Thoracic Society guidelines for influenza vaccinationsIncreasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.Maternal influenza and birth outcomes: systematic review of comparative studies.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).Refining the approach to vaccines against influenza A viruses with pandemic potential.Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus PredominatedInfluenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.Global Trends in Extracorporeal Membranous Oxygenation Use and Survival of Patients With Influenza-Associated IllnessSafety of live attenuated influenza vaccine in atopic children with egg allergyCoverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation.Improving influenza vaccination coverage in the pediatric asthma population: the case for combined methodologies.Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.Influenza vaccines: challenges and solutions.Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany--results of a database analysis from May 2010 to April 2012.TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice.Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial.Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelObesity and the receipt of influenza and pneumococcal vaccination: a systematic review and meta-analysis.Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.Vaccine Safety Resources for NursesMethylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with InfectionEstimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk statusAssociation Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.Influenza Vaccination Coverage Among People With High-Risk Conditions in the U.S.Risk of anaphylaxis after vaccination in children and adults
P2860
Q26250281-2DD5B1D0-7FF3-403F-8680-4B2A545EE063Q26752546-59BFAB7D-74CF-4A93-ABC7-5C8B2EEFBDC7Q26796300-EA43A382-729B-4EB7-831F-81142571FB0EQ26798166-C2739C53-D211-43B5-97A4-D2A54337990EQ26799457-F75BD2C9-27A8-4344-B4A9-53AF2F74B9C6Q27468685-A0D3B8E1-224A-4678-9CFA-020DF7CCBEBCQ28387786-BCBBC52E-2474-4E43-B9BA-4F1882BC3F98Q28394218-A6198B07-6C57-4811-AAAF-1E5B551234D8Q30205765-5ED57BF3-F1C8-44D7-B310-168C756553A2Q30249815-4543701C-87E8-40B6-A12F-FEED255E843AQ30368005-376DC2C8-F9A4-4956-B7B5-5B2497012608Q30375188-DBC6234A-6A98-4640-971D-2ED6C4F394C9Q30375314-5A23DA24-2770-43E9-ABF3-1030C009568DQ30381595-7B9213B3-A84D-4F75-BFFC-76A020D59059Q30381731-4EF3D422-CE61-4B8A-990B-660DD3FC023BQ30382414-7F2B0DD1-5570-4598-AB57-90D9BECD4596Q30383312-651F4930-1DEB-4D70-84EE-9AD69C5206D3Q30390646-4A633849-E9B0-4DF8-A2A4-C47720F06B0FQ30404934-306F5B9C-C52A-4EAA-827B-1019B958E005Q33840055-B1D6D01A-BB43-4EDF-8ABA-9C1DBDC16D11Q34637501-D7849DF8-FD33-40E4-8F74-06599B301F6BQ35110968-CE093899-C035-49FF-9449-A289808F55EDQ35184572-1E3BB7D7-033B-4ECC-9F36-57CF4720792AQ35669511-ACE0462E-3E08-4088-A272-15C01CF062DFQ35672021-A7F6CBD4-D53A-4459-8661-1DF22694FA0EQ35887773-B68A0961-EA58-491F-AA47-3CCD6CC50850Q35892839-BC53E808-98BF-4A46-BBE2-B3B0A0B77E06Q36023396-5EB2D03B-F49D-4AF8-9FCE-ACECFD36A87BQ36030772-511E02ED-3069-499D-9798-680DDACDCEFBQ36031285-8EA5E427-17E8-4325-99E2-83CC0B9EAC02Q36136123-60D58B07-9F4B-48AB-A514-DFAA651350CDQ36142449-1FD94ED5-E86F-4BD9-BC3B-1D8BCF8917F6Q36173746-678C0907-07CF-4AD1-AFFA-CF4E48E44CC0Q36231510-0ED24F7C-D44A-4D6A-B980-CE77FF800F0EQ36315363-12B19614-8D58-483E-86BC-E2E90DF1E724Q36396691-2A1A64E7-4847-4712-8A9A-C535173809FEQ36506099-6CF0D7EE-E869-4297-BB8C-BC52F6249469Q36518793-67698BB7-0AF8-40E9-AD2A-CC4CD03F5E65Q36628012-A00A7AEF-5A93-4603-8630-F073F129AAECQ36665226-6549611C-923D-4913-BCAF-96E4F436DA5A
P2860
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Prevention and control of seas ...... tes, 2014-15 influenza season.
@ast
Prevention and control of seas ...... tes, 2014-15 influenza season.
@en
Prevention and control of seas ...... tes, 2014-15 influenza season.
@nl
type
label
Prevention and control of seas ...... tes, 2014-15 influenza season.
@ast
Prevention and control of seas ...... tes, 2014-15 influenza season.
@en
Prevention and control of seas ...... tes, 2014-15 influenza season.
@nl
prefLabel
Prevention and control of seas ...... tes, 2014-15 influenza season.
@ast
Prevention and control of seas ...... tes, 2014-15 influenza season.
@en
Prevention and control of seas ...... tes, 2014-15 influenza season.
@nl
P2093
P2860
P1476
Prevention and control of seas ...... tes, 2014-15 influenza season.
@en
P2093
Emmanuel B Walter
Joseph S Bresee
Karen R Broder
Leslie Z Sokolow
Lisa A Grohskopf
Nancy J Cox
Sonja J Olsen
P2860
P304
P577
2014-08-01T00:00:00Z